ClinicalTrials.Veeva

Menu

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

University of California (UC) Davis logo

University of California (UC) Davis

Status

Enrolling

Conditions

Antiphospholipid Syndrome

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Enrollment

50 estimated patients

Sex

All

Ages

1 minute to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age or younger at the onset of disease
  • Presence of Vascular Thrombosis
  • UC Davis patient
  • Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma

Exclusion criteria

  • Infants born to mothers with APS
  • Infants with congenital thrombophilia

Trial contacts and locations

1

Loading...

Central trial contact

Lavjay Butani

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems